CClinicalTrials.gg
Status unknownNCT02934100Updated Oct 14, 2016

Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur

An interventional study of Shock Master 300 and Skanlab 25 BODYWAVE in Heel Spur and Calcaneal Spur, sponsored by Medical University of Lodz. Status unknown at 1 site in Poland. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-10-14.

Sponsored by Medical University of Lodz · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Study summary

This study evaluates the effectiveness of physiotherapy and kinesiotherapy in patients with calcaneal spurs. the aim of the study is to compare the efficacy of calcaneal spurs treatment provided with extracorporeal shock wave therapy, ultrasound therapy, electric field diathermy associated with kinesiotherapy and sham laser in combination with kinesiotherapy. In each group kinesiotherapy treatment is the same and consists of an eight-minute massage of posterior lower leg muscles and plantar aponeurosis stretching.

Read the detailed description

Number of 120 diagnosed with heel spur patients, will be allocated randomly into one of three treatment groups or into the control group. Assignment to a group is random, but before that happens patients will be questioned about inclusion and exclusion criteria of the study. Depending on group allocation, patients in treatment groups will receive one of the following physical therapy treatments:

  • ESWT (once a week for 10 weeks)
  • ultrasound (three times a week for 5 weeks)
  • electric field diathermy (three times a week for 5 weeks).

Patients allocated in control group, will receive a sham laser therapy (only the timer on the machine activated) three times a week for 5 weeks.

Regardless of affiliation to the group, each patient will also receive kinesiotherapy treatment.

At the beginning of the study, each patient receives the "Information for the patient," describing the exact course of each stage of the study, then signs a "Form of informed consent to participate in the study.". The next stage of the study is to fill in the participant survey questionnaire and physical examination provided by the researcher.

Assessment of improvements will be made twice: right after the therapy and two months later. Every stage of the study is carried out by one and the same investigator.

02

Conditions studied

  • Heel Spur
  • Calcaneal Spur

Browse trials for

Keywords

  • Calcaneal spur
  • Heel spur
  • ESWT
  • Extracorporeal shock wave therapy
  • ultrasound therapy
  • electric field diathermy
  • skanlab 25 bodywave
  • sham laser therapy
03

In context

Heel Spur

26 studies on the registry are indexed under Heel Spur; 8 are open to participants now.

This study's planned enrollment of 120 is above the median of 55 across 20 interventional studies indexed under Heel Spur.

Browse Heel Spur studies →

Lead sponsor

Medical University of Lodz is the lead sponsor of 101 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • heel spur (calcaneal spur) diagnosed by a doctor based on X-ray examination, diagnostic ultrasonography or MR
  • signed informed consent
  • heel pain for at least one month

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • generalized acute infection (fever, cough, runny nose)
  • local infection in the treated leg (wound, swelling)
  • cancer
  • injections of corticosteroids in the last six weeks
  • pacemaker
  • acute inflammation of the joints of the lower limbs
  • inflammation of the veins
  • Fresh fractures, post-traumatic
  • osteoporosis
  • Reynaud's disease
  • Burger disease
  • atherosclerosis
  • after surgery condition before removing stitches
  • High blood pressure
  • after CT with contrast condition in the last two weeks
  • The state of the lumbar puncture
  • Strong imbalance
  • Condition after myocardial infarction in the last six weeks
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Significant leg ulcers
  • diabetes
  • The risk of bleeding in the muscle tissue
  • Thromboangiitis
  • Hypersensitivity skin in the treated section
  • A tendency to hemorrhage
  • Pathological arrogance bone under the skin in the treated section
  • Metal implants and surgical implants in the area of the lower limb subjected to therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Group 1 - ESWT Treatment

    Patients treated with Extracorporeal Shock Wave Therapy once a week for 10 weeks

    Device: Shock Master 300

  • Active comparator
    Group 2 - Body Wave

    Patients treated with electric field diathermy three times a week for 5 weeks

    Device: Skanlab 25 BODYWAVE

  • Active comparator
    Group 3 - Ultrasound

    Patients treated with ultrasound therapy three times a week for 5 weeks

    Device: EVO US13 CosmoGamma

  • Sham comparator
    Group 4 - Control group

    Patients treated with sham laser therapy three times a week for 5 weeks

    Device: Sham LASER CTL1106MX

Interventions

  • DeviceShock Master 300

    Extracorporeal Shock Wave Therapy In all treatments (from 1 to 10) applied number of pulses is 4500 and the frequency is based on the patients feelings (from 8 to 12 Hz). Variable is the pressure: Treatment 1 - 2,5 Bar; Treatment 2 - 2,6 Bar; Treatment 3 - 2,7 Bar; Treatment 4 - 2,8 Bar; Treatment 5 - 3,0 Bar; Treatment 6 - 3,2 Bar; Treatment 7 - 3,4 Bar; Treatment 8 - 3,6 Bar; Treatment 9 - 3,8 Bar; Treatment 10 - 4,0 Bar. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

    Also known as: produced by GYMNA

  • DeviceSkanlab 25 BODYWAVE

    Electric field diathermy therapy - Capacitive energy transfer system (CETS) Time of each treatment (from 1 to 15) is eight minutes. Variable is the energy: Treatment 1 - 3; Treatment 2 - 3; Treatment 3 - 4; Treatment 4 - 4; Treatment 5 - 5; Treatment 6 - 5; Treatment 7 - 6; Treatment 8 - 6; Treatment 9 - 7; Treatment 10 - 7; Treatment 11 - 7; Treatment 12 - 7; Treatment 13 - 7; Treatment 14 - 7; Treatment 15 - 7. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

    Also known as: produced by SKANLAB AS

  • DeviceEVO US13 CosmoGamma

    Ultrasound therapy Doses applied as following: Each treatment (from 1 to 15) is pulsed ultrasound (1MHz, pulsed 1:4). Variable is the time and intensity: Treatment 1 - 4 minutes, 0,4 W/cm2; Treatment 2 - 5 minutes, 0,4 W/cm2; Treatment 3 - 5 minutes, 0,5 W/cm2; Treatment 4 - 6 minutes, 0,5 W/cm2; Treatment 5 - 6 minutes, 0,6 W/cm2; Treatment 6 - 6 minutes, 0,6 W/cm2; Treatment 7 - 6 minutes, 0,6 W/cm2; Treatment 8 - 6 minutes, 0,7 W/cm2; Treatment 9 - 7 minutes, 0,7 W/cm2; Treatment 10 - 7 minutes, 0,7 W/cm2; Treatment 11 - 7 minutes, 0,8 W/cm2; Treatment 12 - 8 minutes, 0,8 W/cm2; Treatment 13 - 8 minutes, 0,8 W/cm2; Treatment 14 - 8 minutes, 0,8 W/cm2; Treatment 15 - 8 minutes, 0,8 W/cm2. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

    Also known as: produced by EMILDUE

  • DeviceSham LASER CTL1106MX

    Sham laser therapy Time of each treatment (from 1 to 15) is four to five minutes. Developed is 10 points, each point takes 15 seconds. Device is unplugged and it does not emit any radiation.The patient does not know that the procedure is not really executed. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

    Also known as: produced by CTL

06

What researchers measure

Primary outcomes

  1. The American Orthopedic Foot and Ankle Society Score (AOFAS) - Change

    The American Orthopedic Foot and Ankle Society Score (AOFAS) is one of most widely used clinician-reporting tools for foot and ankle conditions. Developed in 1994, it is a clinician-based score that measures outcomes for four different anatomic regions of the foot: The ankle-hindfoot, midfoot, metatarsophalangeal (MTP)-interphalangeal (IP) for the hallux, and MTP-IP for the lesser toes. The four anatomic regions of the AOFAS are all represented by a different version of the survey with each tool designed to be used independently. The questionnaire consists of nine items that are distributed over three categories: Pain (40 points), function (50 points) and alignment (10 points). These are all scored together for a total of 100 points.

    Time frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

  2. The SF-36v2 Health Survey (SF-36v2) - Change

    The SF-36v2 Health Survey is a multipurpose, short-form health survey with 36 questions that yields an eight-scale profile of functional health and well-being, as well as two psychometrically based physical and mental health summary measures and a preference-based health utility index. Like its predecessor, the SF-36 Health Survey , the SF-36v2 is a generic measure of health status, as opposed to one that targets a specific age, disease, or treatment group. It has proven useful for conducting surveys of general and specific populations, comparing the relative burden of diseases, and differentiating the health benefits produced by a wide range of treatments.

    Time frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

  3. The Laitinen Pain Indicator Questionnaire

    The Laitinen Pain Indicator Questionnaire is subjective and point tool which is used to assess the level of pain. Patients have to evaluate four indicators: pain intensity, the frequency of pain, the frequency of use of analgesics and physical activity limitations. Each indicator score is assigned from 0 to 4, with 0 being no problem, and four being a maximum problem.

    Time frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

Secondary outcomes

  1. Two weights test

    The two weights test is measures the uniformity of the load of the lower limbs. The patient gets the right lower limb on one scale and another limb on the other scale. By standing on the scales must look ahead. The range of measurement error is five kilograms.

    Time frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

  2. Heel standing test

    The heel standing test is to measure the intensity of pain experienced by burdening calcaneus. The patient is standing by the wall and must stand on both heel bones at the same time, then turn on the right calcaneus and then on the left calcaneus. Each of the three above mentioned activities is assessed using a three-point scale, depending on the feasibility of the task by the patient: job done at 100-75% without much problem, the task done at 75-25% with difficulty, the task done at 25-0% with great difficulty, or not done at all. The test was created for this study and a researcher authorship.

    Time frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

  3. The Visual Analogue Scale

    The visual analogue scale is a measurement instrument that is used for subjective assessment of pain made by the patient. The pain can be evaluated in a ten-point scale, where one represents no pain and ten is the pain unbearable.

    Time frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02934100
Lead sponsor
Medical University of Lodz
Responsible party
Natalia Kociuga (Master of Physical Therapy, Medical University of Lodz) — Principal investigator
First posted
Oct 14, 2016
Start date
Aug 2016
Primary completion
Aug 2017 (estimated)
Completion
Jun 2018 (estimated)
Last update
Oct 14, 2016

Study contacts

Natalia Kociuga, master
Contact
nkociuga@gmail.com
+48609018609
Marta Woldańska-Okońska, professor
Contact
marta.woldanska-okonska@umed.lodz.pl
+48662130860
Natalia Kociuga, master
principal investigator · Medical University of Lodz, Poland

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion